# US 2012/0259004 A1 · Anti-cancer extract and compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0259004 A1
- Document ID: US20120259004A1
- Status: Published application
- Kind: A1
- Application number: 13/249,904
- Filed: 2011-09-30
- Published: 2012-10-11
- Earliest claimed: 2010-09-30
- Assignees: National Yang-Ming University
- Inventors: Chi-Ying Huang
- Web page: https://patentgrep.com/patent/US20120259004A1

## CPC

- A61K 36/41: Crassulaceae (Stonecrop family)
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 2236/30: Extraction of the material
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The preset invention relates to a new approach for treating a cancer or fibrosis, such as Hepatocellular carcinoma, or liver fibrosis using an extract from a plant of Graptopetalum sp., Rhodiola sp. or Echeveria sp., and prepared by extracting the plant with Dimethyl sulfoxide (DMSO), its fraction or the compound isolated from the extract.

## Claims

### Claim 1

An extract with anti-cancer activity, which is extracted with Dimethyl sulfoxide (DMSO) from a plant of Graptopetalum sp., Rhodiola sp. or Echeveria sp.

### Claim 2 (depends on 1)

The extract of claim 1, wherein the plant is Graptopetalum paraguayense or Rhodiola rosea.

### Claim 3 (depends on 1)

The extract of claim 1, which has a therapeutic effect on liver cancer.

### Claim 4 (depends on 1)

The extract of claim 1, which has a therapeutic effect on Hepatocellular carcinoma (HCC).

### Claim 5 (depends on 1)

A composition comprising a therapeutically effective amount of the extract of claim 1.

### Claim 6 (depends on 1)

A method for preventing or treating a cancer comprising administrating a subject in need thereof with an therapeutically effective amount of the extract of claim 1.

### Claim 7 (depends on 6)

The method of claim 6, wherein the cancer is liver cancer.

### Claim 8 (depends on 6)

The method of claim 6, wherein the liver cancer is Hepatocellular carcinoma (HCC).

### Claim 9

A fraction containing rich anti-cancer components from a plant selected from the group consisting of Graptopetalum sp., Rhodiola sp. and Echeveria sp, which is prepared by extracting the plant with Dimethyl sulfoxide (DMSO), and then isolating by chromatography to obtain a fraction called as HH-F3.

### Claim 10 (depends on 9)

The fraction of claim 9, which has effects in causing cytotoxicity and down-regulating AURKA, AURKB, and FLJ10540 expression in cancer cells.

### Claim 11 (depends on 9)

The fraction of claim 9, wherein a Sephadex LH-20 column is used for chromatography.

### Claim 12 (depends on 9)

The fraction of claim 9, wherein the plant is Graptopetalum paraguayense or Rhodiola rosea.

### Claim 13 (depends on 9)

The fraction of claim 9, which has a therapeutic effect on liver cancer.

### Claim 14 (depends on 9)

The fraction of claim 9, which has a therapeutic effect on Hepatocellular carcinoma (HCC).

### Claim 15 (depends on 9)

A pharmaceutical composition comprising a therapeutically effective amount of the fraction of claim 9, and a pharmaceutically acceptable carrier.

### Claim 16 (depends on 9)

A method for preventing or treating a cancer comprising administrating a subject in need thereof with an therapeutically effective amount of the fraction of claim 9.

### Claim 17 (depends on 16)

The method of claim 16, wherein the cancer is liver cancer.

### Claim 18 (depends on 16)

The method of claim 16, wherein the liver cancer is Hepatocellular carcinoma (HCC).

### Claim 19

A compound, having a structure of formula I
wherein one of the R's is H, or prucyanidin (PC) unit, and the other are OH or prodelphindine (PD) unit; n is a number ranging from 21 to 38; and the ratio of PC unit to PD unit is not more than 1:20.

### Claim 20 (depends on 19)

The compound of claim 19, which is isolated from the extract of a plant selected from the group consisting of Graptopetalum sp., Rhodiola sp. and Echeveria sp.

### Claim 21 (depends on 19)

The compound of claim 19, which is isolated from Graptopetalum paraguayense or Rhodiola rosea.

### Claim 22 (depends on 19)

A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 19, and a pharmaceutically acceptable carrier.

### Claim 23 (depends on 22)

The pharmaceutical composition of claim 22, which has an anti-cancer activity.

### Claim 24 (depends on 19)

A pharmaceutical composition for prevention or treatment of a cancer, comprising a therapeutically effect amount of the compound of claim 19, and a pharmaceutically acceptable carrier.

### Claim 25 (depends on 24)

The pharmaceutical composition of claim 24, wherein the cancer is liver cancer.

### Claim 26 (depends on 25)

The pharmaceutical composition of claim 25, wherein the liver cancer is Hepatocellular carcinoma (HCC).

### Claim 27 (depends on 19)

A method for preventing or treating a cancer comprising administrating a subject in need thereof with an therapeutically effective amount of the compound of claim 19.

### Claim 28 (depends on 27)

The method of claim 27, wherein the cancer is liver cancer.

### Claim 29 (depends on 28)

The method of claim 28, wherein the liver cancer is Hepatocellular carcinoma (HCC).

### Claim 30 (depends on 19)

A method for preventing or treating a fibrosis comprising administrating a subject in need thereof with an therapeutically effective amount of the compound of claim 19.

### Claim 31 (depends on 30)

The method of claim 30, wherein the fibrosis is liver fibrosis.
